Nissay Asset Management Corp 10x Genomics, Inc. Transaction History

Nissay Asset Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $311,340 - $694,386	-8,426 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $15,818 - $41,404	284 Added 3.49%	8,426 $641,000
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $11,344 - $15,337	84 Added 1.04%	8,142 $1.21 Million
Q3 2021 Nov 10, 2021	BUY	$145.58 - $192.14 $53,136 - $70,131	365 Added 4.74%	8,058 $1.17 Million
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $86,974 - $131,135	648 Added 9.2%	7,693 $1.51 Million
Q1 2021 May 11, 2021	BUY	$140.25 - $196.86 $10,518 - $14,764	75 Added 1.08%	7,045 $1.28 Million
Q4 2020 Feb 08, 2021	BUY	$126.47 - $163.7 $881,495 - $1.14 Million	6,970 New	6,970 $987,000

290

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.36B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Nissay Asset Management Corp with notifications on news.